WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
News & Events
Maps & Locations
PATIENT AND VISITOR INFORMATION
PREVENTION AND SCREENING
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Content Block Control
RETURN TO SEARCH RESULTS
A Randomized Phase II Study of Rituximab with ABVD Versus Standard ABVD for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor Risk Features (IPS Score > 2)
The goal of this clinical research study is to compare the effectiveness of receiving adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) therapy alone to receiving ABVD with rituximab.
Up to 120 patients will take part in this study. Up to 10 will be enrolled at Washington University.
(Links will take you off this web site)
Internal Protocol Documents (requires Siteman administrative database password)
© 2009 All rights reserved